This is a preprint.
Complimentary vertebrate Wac models exhibit phenotypes relevant to DeSanto-Shinawi Syndrome
- PMID: 38826421
- PMCID: PMC11142245
- DOI: 10.1101/2024.05.26.595966
Complimentary vertebrate Wac models exhibit phenotypes relevant to DeSanto-Shinawi Syndrome
Abstract
Monogenic syndromes are associated with neurodevelopmental changes that result in cognitive impairments, neurobehavioral phenotypes including autism and seizures. Limited studies and resources are available to make meaningful headway into the underlying molecular mechanisms that result in these symptoms. One such example is DeSanto-Shinawi Syndrome (DESSH), a rare disorder caused by pathogenic variants in the WAC gene. Individuals with DESSH syndrome exhibit a recognizable craniofacial gestalt, developmental delay/intellectual disability, neurobehavioral symptoms that include autism, ADHD, behavioral difficulties and seizures. However, no thorough studies from a vertebrate model exist to understand how these changes occur. To overcome this, we developed both murine and zebrafish Wac/wac deletion mutants and studied whether their phenotypes recapitulate those described in individuals with DESSH syndrome. We first show that the two Wac models exhibit craniofacial and behavioral changes, reminiscent of abnormalities found in DESSH syndrome. In addition, each model revealed impacts to GABAergic neurons and further studies showed that the mouse mutants are susceptible to seizures, changes in brain volumes that are different between sexes and relevant behaviors. Finally, we uncovered transcriptional impacts of Wac loss of function in mice that will pave the way for future molecular studies into DESSH. These studies present two new animals that begin to uncover some biological underpinnings of DESSH syndrome and elucidate the biology of Wac.
Conflict of interest statement
Conflict of interests The authors report that they have no conflict of interests.
Figures
References
-
- DeSanto C, D’Aco K, Araujo GC, Shannon N, DDD Study, Vernon H, et al. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome. J Med Genet. 2015;52:754–761. - PubMed
-
- Alawadhi A, Morgan AT, Mucha BE, Scheffer IE, Myers KA. Self-limited focal epilepsy and childhood apraxia of speech with WAC pathogenic variants. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc. 2021;30:25–28.
-
- Morales JA, Valenzuela I, Cuscó I, Cogné B, Isidor B, Matalon DR, et al. Clinical and molecular characterization of five new individuals with WAC-related intellectual disability: Evidence of pathogenicity for a novel splicing variant. Am J Med Genet A. 2022. 12 January 2022. 10.1002/ajmg.a.62648. - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases